Features of conservative therapy of benign prostatic hyperplasia in patients with metabolic syndrome: " Treat to Target "
Purpose of the study. To improve the results of treatment of benign prostatic hyperplasia with symptoms of the lower urinary tract in the presence of concomitant metabolic syndrome.Materials and methods. The investigation included 103 patients aged 42 to 75 years with a reliable diagnosis of BPH and...
Saved in:
Main Authors: | V. B. Filimonov, P. V. Vasin, V. N. Panchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2020-12-01
|
Series: | Исследования и практика в медицине |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/635 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
by: Mohamad Baker Berjaoui, et al.
Published: (2024-11-01) -
IMPROVING THE QUALITY OF PROSTATE TRANSURETHRAL RESECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA THROUGH INTRAOPERATIVE TRANSRECTAL ULTRASOUND MONITORING OF THE REMOVED TISSUE VOLUME
by: V. B. Filimonov, et al.
Published: (2019-06-01) -
Association between Chinese visceral adiposity index and lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a national cohort study
by: Kunhui Chang, et al.
Published: (2025-01-01) -
The effect of systemic hypertension on prostatic arterial hemodynamics in dogs with benign prostate hyperplasia
by: Çağatay ESİN
Published: (2024-11-01) -
Asthma-associated prostate enlargement and bladder smooth muscle hypercontractility: unveiling a potential link to LUTS
by: Peibin Cen, et al.
Published: (2025-01-01)